MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

The phenotype of ATP1A3+ Rapid-Onset Dystonia-Parkinsonism (RDP) is broader than previously defined

I. Haq, B. Snively, C. Suerken, J. Cook, C. Miller, K. Sweadner, L. Ozelius, C. Whitlow, A. Brashear (Winston Salem, NC, USA)

Meeting: 2018 International Congress

Abstract Number: 731

Keywords: Dystonia: Clinical features, Dystonia: Genetics, Rapid-onset dystonia-parkinsonism(RDP)

Session Information

Date: Sunday, October 7, 2018

Session Title: Dystonia

Session Time: 1:45pm-3:15pm

Location: Hall 3FG

Objective: To update the phenotype of RDP based on a cohort of ATP1A3 mutation+ individuals.

Background: RDP is caused by mutations of the ATP1A3 gene, which encodes the α3 subunit of the Na+/K+ ATPase. The published phenotype of RDP is typified by a rostral to caudal gradient of effect, bulbar dysfunction, and abrupt symptom onset. Our group has reexamined the RDP phenotype in a cohort of 53 mutation-positive subjects (ATP1A3+) with 12 distinct mutations.

Methods: We analyzed the cohort with respect to mean Unified Parkinson’s Disease Rating motor subscale (UPDRS3) and Burke-Fahn-Marsden Dystonia Rating Scale (BMFDRS) scores, symmetric parkinsonism, and the presence of bulbar symptoms, a rostrocaudal symptom gradient, frontal lobe dysfunction, and cerebellar dysfunction.

Results: Rapidity of onset (<30 days) was characteristic of ATP1A3+ individuals, but not universal (61%). Bulbar symptoms were present in 81% of ATP1A3+ subjects. ATP1A3+ individuals were dystonic and parkinsonian (mean±SD BMFDRS 47±33 and UPDRS of 44±23). Frontal lobe function measures (trailmaking, verbal fluency) were lower in the ATP1A3+ group than in a control cohort. Neither the presence of a rostrocaudal gradient nor symmetric parkinsonism were typical of the ATP1A3+ cohort. Only 5.8% of ATP1A3+ subjects displayed a rostrocaudal gradient and were about equally likely to have a symmetric or asymmetric parkinsonism (35% symmetric, 48% asymmetric). A subset (n=12) had formal cerebellar function scale assessments, and 17% of these showed cerebellar dysfunction.

Conclusions: ATP1A3+ with RDP subjects typically show rapidity of onset, dystonia, parkinsonism, bulbar symptoms, frontal dysfunction, and possibly cerebellar dysfunction. Neither asymmetric parkinsonism nor the lack of a rostrocaudal gradient can be used to exclude a diagnosis of ATP1A3+ RDP. Our results are affected by the nonhomogenous distribution of mutations, which ranged from 1 instance to 16. Future directions include phenotypic analysis within and between mutation types.

To cite this abstract in AMA style:

I. Haq, B. Snively, C. Suerken, J. Cook, C. Miller, K. Sweadner, L. Ozelius, C. Whitlow, A. Brashear. The phenotype of ATP1A3+ Rapid-Onset Dystonia-Parkinsonism (RDP) is broader than previously defined [abstract]. Mov Disord. 2018; 33 (suppl 2). https://www.mdsabstracts.org/abstract/the-phenotype-of-atp1a3-rapid-onset-dystonia-parkinsonism-rdp-is-broader-than-previously-defined/. Accessed May 14, 2025.
  • Tweet
  • Email
  • Print

« Back to 2018 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/the-phenotype-of-atp1a3-rapid-onset-dystonia-parkinsonism-rdp-is-broader-than-previously-defined/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley